{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T14:19:25Z","timestamp":1715782765486},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162533","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T17:28:57Z","timestamp":1473701337000},"page":"e0162533","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Na\u00efve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series"],"prefix":"10.1371","volume":"11","author":[{"given":"Pukhraj","family":"Rishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Raka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekta","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"ref1","first-page":"125","article-title":"Laser photocoagulation in retinal vein occlusion: branch vein occlusion study and central vein occlusion study recommendations","volume":"45","author":"S Saxena","year":"1997","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2006.12.037","article-title":"Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion","volume":"143","author":"SA Pai","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IAE.0b013e318030e77e","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion","volume":"27","author":"MD Rabena","year":"2007","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"PA Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/OPTH.S30156","article-title":"Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients","volume":"7","author":"V Isola","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3928\/15428877-20090101-04","article-title":"Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema","volume":"40","author":"E Chen","year":"2009","journal-title":"Ophthalmic Surg Lasers"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1755-3768.2008.01175.x","article-title":"Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion","volume":"86","author":"KS Kim","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10792-010-9390-z","article-title":"Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema","volume":"31","author":"N Goel","year":"2011","journal-title":"Int Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/bjo.2009.174060","article-title":"Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up","volume":"95","author":"A Pece","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1167\/iovs.07-0731","article-title":"The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits","volume":"48","author":"H Ameri","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00417-009-1184-5","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angioid streaks in pseudoxanthoma elasticum","volume":"247","author":"M Ganssauge","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/WNO.0b013e3181a58fd1","article-title":"Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab","volume":"29","author":"H Hosseini","year":"2009","journal-title":"J Neuroophthalmol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2353\/ajpath.2007.070385","article-title":"Vascular endothelial cell growth factor-a: not just for endothelial cells anymore","volume":"171","author":"PA D'Amore","year":"2007","journal-title":"Am J Pathol"},{"key":"ref14","first-page":"1707","article-title":"Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation","volume":"247","author":"AA Rouvas","year":"2008","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1755-3768.2008.01187.x","article-title":"Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma","volume":"86","author":"K Yokoyama","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.ophtha.2008.06.021","article-title":"Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions","volume":"115","author":"DJ Pieramici","year":"2008","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10384-010-0841-x","article-title":"Inner neural retina loss in central retinal artery occlusion","volume":"54","author":"F Ikeda","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/IAE.0b013e3182899205","article-title":"In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: A "Prominent Middle Limiting Membrane Sign"","volume":"33","author":"YK Chu","year":"2013","journal-title":"Retina"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2147\/OPTH.S13592","article-title":"Autofluorescence and high-definition optical coherence tomography of retinal artery occlusions","volume":"4","author":"R Mathew","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00156415","article-title":"Foveal avascular zone in macular branch retinal vein occlusion","volume":"19","author":"MB Parodi","year":"1995","journal-title":"Int Ophthalmol"},{"issue":"5 Suppl","key":"ref21","first-page":"807","article-title":"Early Treatment Diabetic Retinopathy Study Research Group Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"ref22","first-page":"298","article-title":"Multifocal electroretinograms in patients with branch retinal artery occlusion","volume":"42","author":"S Hasegawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0021-5155(01)00374-4","article-title":"Multifocal electroretinograms in patients with branch retinal artery occlusion","volume":"45","author":"A Ohshima","journal-title":"Jpn J Ophthalmol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00006982-200603000-00007","article-title":"Multifocal electroretinography and fluorescein angiography in retinal vein","volume":"26","author":"C Hvarfner","year":"2006","journal-title":"Retina"},{"key":"ref25","first-page":"84","article-title":"Multifocal electroretinograms in patients with retinal vein occlusion","volume":"108","author":"J Ikeda","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2002-30653","article-title":"Local visual field defects correlate with the multifocal electroretinogram (mfERG) in retinal vascular branch occlusion","volume":"219","author":"H Wildberger","year":"2002","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","article-title":"Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study","volume":"18","author":"DM Brown","year":"2011","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for Macular Edema following Central Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study","volume":"117","author":"DM Brown","year":"2010","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e4203","DOI":"10.1136\/bmj.e4203","article-title":"Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study","volume":"345","author":"RJ Campbell","year":"2012","journal-title":"BMJ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:46:02Z","timestamp":1588981562000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162533"}},"subtitle":[],"editor":[{"given":"Raja","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162533","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}